I would recommend a HOLD on ULTRACEMCO, as the short-term gains are promising, but the longer-term returns are not impressive, and the volatility is relatively low. The Sharpe Ratio, although above 1, is not exceptional, suggesting that the returns are not significantly exceeding the risk taken.